Table 1.
Patient characteristics
| Men | Women | |
|---|---|---|
| n (%) | 117 (50%) | 117 (50%) |
| Age (years) | 67.0 (58.0–72.0) | 65.5 (53.3–72.8) |
| Diabetic retinopathy (−/+) | 108/8 | 105/12 |
| Diabetic nephropathy (−/+) | 90/27 | 91/26 |
| Diabetic neuropathy (−/+) | 105/12 | 100/17 |
| Cardiovascular disease (−/+) | 102/15 | 111/6 |
| Fracture(−/+) | 114/3 | 113/4 |
| Body mass index (kg/m2) | 23.8 (21.9–25.9) | 25.1 (21.5–28.0) |
| Skeletal mass index (kg/m2) | 7.55 (6.88–8.09) | 6.38 (5.75–7.01) |
| Systolic blood pressure (mmHg) | 134 (124–144) | 135 (125–141) |
| Diastolic blood pressure (mmHg) | 80.0 (73.0–86.0) | 79.5 (69.0–85.0) |
| Hemoglobin A1c (%) | 7.5 (6.3–8.7) | 7.2 (6.5–8.2) |
| Total cholesterol (mg/dL) | 185 (166–211) | 208 (182–230) |
| Triglycerides (mg/dL) | 113 (77–174) | 128 (81–161) |
| Creatinine (mg/dL) | 0.84 (0.74–1.05) | 0.63 (0.56–0.70) |
| Smoking (never/previous/current) | 67/31/19 | 105/9/3 |
| Drinking (never/social/everyday) | 110/3/4 | 112/3/2 |
| Antidiabetic drug (−/+) | 30/87 | 29/88 |
| Antihypertensive drug (−/+) | 67/50 | 67/50 |
| Antihyperlipidemic drug (−/+) | 93/24 | 81/36 |
| Drug for treatment of osteoporosis (−/+) | 115/2 | 113/4 |
| Grip strength (kg) | 37.0 (30.8–41.3) | 23.0 (19.0–27.0) |
| Loco‐check (non‐LS/positive LS) | 30/8 | 31/11 |
| Stand‐up test (non‐LS/LS stage 1/LS stage 2) | 61/41/14 | 51/40/24 |
| Two‐step test (non‐LS/LS stage 1/LS stage 2) | 33/81/1 | 15/94/5 |
For categorical variables, n (%) is presented. For continuous variables, median (interquartile range) is presented. LS, locomotive syndrome.